Importantly, low expression of OTUD3 significantly predicted poorer tumor relapse-free survival (RFS) and overall survival (OS) in esophageal cancer patients (Fig. 1g), and this effect was more significant in the heavy-smoking patients than those in non-smokers (Supplementary Fig. 2c, d). This evidence concerns the gene OTUD3 and esophageal cancer.